The Patent Finder

(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof

Amgen Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 61/601,226, filed Feb 21, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 7,662,847Methods of Using N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds
In force
 · High confidence
Amgen Inc.In force
High confidence
US 7,427,638(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione:, and Methods of Synthesis and Compositions Thereof
In force
 · High confidence
Amgen Inc.In force
High confidence
US D735,315Pharmaceutical Tablet
In force
 · High confidence
Amgen Inc.In force
High confidence
US 9,616,019Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
In force
 · High confidence
Amgen Inc.In force
High confidence
US 9,023,886Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
In force
 · High confidence
Amgen Inc.In force
High confidence
US 9,532,977Controlled Release Oral Dosage Forms of Poorly Soluble Drugs and Uses Thereof
In force
 · High confidence
Amgen Inc.In force
High confidence
US 9,045,417Isotopologues of Isoindole Derivatives
In force
 · High confidence
Amgen Inc.In force
High confidence
US 9,642,836Isotopologues of Isoindole Derivatives
In force
 · High confidence
Amgen Inc.In force
High confidence
US 8,853,175Phenethylsulfone Isoindoline Derivatives and Their Use
In force
 · High confidence
Amgen Inc.In force
High confidence
US 9,387,195Methods for Treating Diseases Using Isoindoline Compounds
In force
 · High confidence
Amgen Inc.In force
High confidence
52 more patents in this group · Pro
10 of 62 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 62, including 32 expired and 2 expiring within the 18 months from Nov 16, 2026.
Upgrade to Pro
26 of these are in force and held by Amgen Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited